Design Therapeutics Inc (DSGN) PT Lowered to $8 at Goldman Sachs

March 15, 2022 3:37 AM EDT Send to a Friend

Goldman Sachs analyst Madhu Kumar ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Design Therapeutics Inc (DSGN) PT Lowered to $8 at Goldman Sachs

Member Login

Free News Feed